|
IPMK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.30739996606621E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.87950038549923E-10 |
| Normal-vs-Stage2 |
4.315700E-03 |
| Normal-vs-Stage3 |
1.015810E-03 |
| Normal-vs-Stage4 |
3.925900E-02 |
| Stage1-vs-Stage2 |
8.332800E-01 |
| Stage1-vs-Stage3 |
4.941200E-01 |
| Stage1-vs-Stage4 |
3.144000E-02 |
| Stage2-vs-Stage3 |
7.729200E-01 |
| Stage2-vs-Stage4 |
1.857390E-01 |
| Stage3-vs-Stage4 |
2.452200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.12460099197665E-11 |
| Normal-vs-AfricanAmerican |
8.752000E-01 |
| Normal-vs-Asian |
1.440250E-01 |
| Caucasian-vs-AfricanAmerican |
5.50459999999475E-05 |
| Caucasian-vs-Asian |
6.159400E-01 |
| AfricanAmerican-vs-Asian |
3.299800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48210000050497E-07 |
| Normal-vs-Female |
1.86399999990705E-07 |
| Male-vs-Female |
5.139600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.000760E-01 |
| Normal-vs-Age(41-60Yrs) |
5.48399999855675E-08 |
| Normal-vs-Age(61-80Yrs) |
1.56149999996913E-06 |
| Normal-vs-Age(81-100Yrs) |
8.561800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.023400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.363400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.241000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.349600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.516800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.924000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.607900E-02 |
| Normal-vs-Grade 2 |
3.92370003154952E-09 |
| Normal-vs-Grade 3 |
4.81870000001994E-06 |
| Normal-vs-Grade 4 |
4.304000E-02 |
| Grade 1-vs-Grade 2 |
9.260200E-01 |
| Grade 1-vs-Grade 3 |
6.262000E-01 |
| Grade 1-vs-Grade 4 |
4.183200E-01 |
| Grade 2-vs-Grade 3 |
2.637600E-01 |
| Grade 2-vs-Grade 4 |
1.046180E-01 |
| Grade 3-vs-Grade 4 |
4.117200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.18439710764073E-11 |
| Normal-vs-ccB subtype |
1.91880000000033E-05 |
| ccA subtype-vs-ccB subtype |
3.108200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.89209994525686E-09 |
| Normal-vs-N1 |
1.994030E-01 |
| N0-vs-N1 |
7.699600E-01 |
|
|
